first edition (1980) of the Orange Book - FDA Law Blog

More documents

Recommendations

Info

APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST16BETAMETHASONE BENZOATEOINTMENT; TOPICALBENISONEPARKE-DAVISIW-LBETAMETHASONE DIPROPIONATEAEROSOL; TOPICALiHPROSONESCHERINGCREAM; TOPICALDIPROSONESCHERINGLOTION; TOPICALDIPROSONESCHERINGOINTMENT; TOPICALDIPROSONESCHERINGBETAMETHASONE SODIUM PHOSPHATEO.025XEQ 5MG BASE/S5GMEQ O.5MG BASE/GMEQ O.5MG BASE/GMEQ O.SMG BASE/GMINJECTABLE; INJECTIONBETAMETHASOHE SODZUM PHOSPHATEAP CART~R-GLOGAU LABS Eg 3MB BASEIMLCELEST,OHEAP SCHERING EQ 3MB BASE/MLBETAMETHASONE SODIUM PHOSPHATE; *MULTIPLE*SEE BETAHETHASONE ACETATE; BETAHETHASONE SODIUH PHOSPHATEBETAHETHASONE VALERATEAEROSOL; TOPICALVALISONESCHERINGCREAM; TOPICALVALISONESCHERINGEQ 7.SMG BASE/SSGMEQ O.lHG'BASE/GM * EQ IMG BASE/GNBETAMETHASONE VALERATELOTION; TOPICALVALISONESCHERINGOINTMENT; TOPICALVALISONESCHERINGBETAZOLE HYDROCHLORIDEINJECTABLE; INJECTIONHISTALOGELI LILLYBETHANECHOL CHLORIDEINJECTABLE; INJECTIONURECHOLINEMERCK SHARP & DOHMEEQ IMG BASE/GMEQ IMG BASE/GMSOMG/MLSMG/MLTABLET; ORALBETHAHECHOL CHLORZDEAA BOLAR PHARM 5MB it 10MB M 25MBAA CHELSEA LABS 5MB M ~ M 25MBAA DANBURY PHARMACAL 5MB M lOMG M 25MBAA LANNETT 5MB M ~ M 25MGAA VITARINE/WEST CHEM 5MG M lOMG M 25MGAA ZENITH LABS 25MB~AA NORWICH-EATON PHARM ~ M 25MB M 50MBMYOTDHACHDLAA GLENWOOD LABS 5MB M 10MB M 25MGURECHOLIHEAA MERCK SHARP & DOHME 5MB M 10MB M 25MB M M!!:l§BIPERIDEN HYDROCHLORIDETABLET; ORALAKINETONKNOLL PHARM2MG
APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST17BIPERIDEN LACTATEINJECTABLE; INJECTIONAKINETON LACTATEKNOLL PHARMBISHYDROXYCOUMARINCAPSULE; ORALDICUNAROLELI LILLYTABLET; ORALDICUMAROLABBOTT LABSBLEOMYCIN SULFATEINJECTABLE; INJECTIONBLENOXANENIPPON KAYAKU COBRETYLIUN TOSYLATEINJECTABLE; INJECTIONBRETYlOLAMER CRIT CARE/AHSCBROMOCRIPTINE MESYLATETABLET; ORALPAR LODElSANDOZ PHARMS5MG/ML25MG * 50NG25MG * 50MG * 100MGEQ 15 UNITS BASE/VIAL50MG/MLEQ 2.5MG BASEBROMODIPHENHYDRAMINE HYDROCHLORIDECAPSULE; ORALAMBODRYl HCLPARKE-DAVIS/W-LElIXIR; ORALAMBODRYl HCLPARKE-DAVIS/W-L25MG12.5MG/5HLBROMPHENIRAMINE MALEATEELIXIR; ORALBROMPHEI~IRAMIHE MALEATEAA HEUN-NORWOOD LABS ZMG/5MLCORTAHEAA CORD LABS ZMG/5MLDIMETAHEAA AH ROBINS ZMG/5MLINJECTABLE; INJECTIONBROMPHEHIRAMIHE MALEATEAP CARTER-GLOGAU LABS lOMG/MLDIMETAHE-TEHAP AH ROBINS lOMG/MLTABLET; ORALBROMPHEHIRAMIHE MALEATEAA ANABOLIC 4MGAA BARR LABS 4MGAA BOLAR PHARN 4MGAA CHELSEA LABS 4MGAA CORD LABS 4MGAA DANBURY PHARMACAL 4MGAA LEMMON PHARMACAL 4MGAA NEWTRON PHARMS 4MGAA PHOENIX LABS 4MGAA PRIVATE FORMULATIONS 4MGAA PUREPAC PHARM 4MGAA TABLICAPS 4MGAA ZENITH LABS 4MGDIMETAHEAA AH ROBINS 4MGVELTAHEAA LANNETT 4MGBUCLIZINE HYDROCHLORIDETABLET; ORALBUCLADIN-SSTUART PHARHS/ICIBUPIVACAINE HYDROCHLORIDEINJECTABLE; INJECTIONBUPIVACAIHE HCLAP ABBOTT LABS50HGO.Z5Z If 0.5Z If 0.757.
Page 5: RXD AND DRUG ACMINISTRATIONAPProVED
Page 9: approved application, a list of app
Page 12 and 13: products that have been approved" i
Page 14 and 15: To assist the user in relating the
Page 16 and 17: an evaluatien of therapeutic equiva
Page 18 and 19: ioavailability data is required for
Page 20 and 21: B - Drug products that FDA does not
Page 22 and 23: and the rate of absorption.pharmace
Page 24 and 25: 4. Erythromycin stearate Tablets -
Page 27 and 28: II. LISTINGSA. FORMAT GUIDEThis p..
Page 29 and 30: CURRENT STATUS - POSSIBLY EFFECTIVE
Page 31 and 32: DRUG ProDUCT EKAMPLESSingle Ingredi
Page 33 and 34: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 47: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 55 and 56: j./APPROVED PRESCRIPTION DRUG PRODU
Page 65 and 66: -,----APPROVED PRESCRIPTION DRUG PR
Page 67 and 68: APPROVED PRESCRI~TIOHDRUG PRODUCTSD
Page 77 and 78: DIMENHYDlHNATEAPPROVED PRESCRIPTION
Page 81 and 82: ------"".,APPROVED PRESCRIPTION DRU
Page 91 and 92: APPROVED ¥RESCRIPTION DRUG PRODUCT
Page 95 and 96: '''"APPROVED PRESCRIPTION DRUG PROD
Page 97 and 98: ----..//APPROVED PRESCRIPTION DRUG
Page 99 and 100:
APPROVED PRESCRIPTION DRUG PRODUCTS
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
"~''''''-- .APPROVED PRESCRIPTION D
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
PERCORTEN PIVALATE, DESOXYCORTICOST
Page 191 and 192:
Page 193 and 194:
Page 195:
oAPPROVED PRESCRIPTION DRUG PRODUCT
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
APPROVED PRESCRIPTIOH DRUG PRODUCTS
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243:
Page 246 and 247:
PRESCRIPTION DRUG PRODUCTS DEEMED A
Page 248 and 249:
Page 250 and 251:
show all

first edition (1980) of the Orange Book - FDA Law Blog

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?